Literature DB >> 17213340

Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.

Tsuyoshi Konishi1, Toshiaki Watanabe, Junji Kishimoto, Kenjiro Kotake, Tetsuichiro Muto, Hirokazu Nagawa.   

Abstract

BACKGROUND: Colorectal carcinoids are often described as low-grade malignant. However, no study has compared the survival between patients with colorectal carcinoids and those with carcinomas, in a large series. In addition, no global consensus has been established on the crucial determinants of metastasis in colorectal carcinoids. AIM: To determine the predictive factors for metastasis in colorectal carcinoids and clarify their prognosis compared with adenocarcinomas.
METHODS: Data of all patients diagnosed as having colorectal carcinoids were extracted from a large nationwide database of colorectal tumours, the Multi-Institutional Registry of Large-Bowel Cancer in Japan, for the period from 1984 to 1998. Risk factors for lymph node (LN) metastases and distant metastases were analysed among those who were undergoing surgery, by univariate and multivariate analysis. Cancer-specific survival was also compared between patients with colorectal carcinoids and those with adenocarcinomas registered in the same period.
RESULTS: Among the 90 057 cases of colorectal tumours that were diagnosed, a total of 345 cases of carcinoids were identified, including 247 colorectal carcinoids of those undergoing surgery. Risk factors for LN metastasis were tumour size >/=11 mm and lymphatic invasion, whereas those for distant metastasis were tumour size >/=21 mm and venous invasion. Colorectal carcinoids without these risk factors exhibited no LN metastasis or distant metastasis. Cancer-specific survival of patients with colorectal carcinoids without metastasis was better than that of those with adenocarcinomas. However, the survival was similar between carcinoids and adenocarcinomas if the tumours had LN metastasis or distant metastasis.
CONCLUSIONS: The presence of metastasis in colorectal carcinoids could lead to survival that is as poor as in adenocarcinomas. Tumours </=10 mm and without lymphatic invasion could be curatively treated by local resection, but others would need radical LN dissection.

Entities:  

Mesh:

Year:  2007        PMID: 17213340      PMCID: PMC1954860          DOI: 10.1136/gut.2006.109157

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Metastatic neuroendocrine hepatic tumors: resection improves survival.

Authors:  Sandeepa Musunuru; Herbert Chen; Sharad Rajpal; Nicholas Stephani; John C McDermott; Kyle Holen; Layton F Rikkers; Sharon M Weber
Journal:  Arch Surg       Date:  2006-10

2.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

3.  Cancer incidence and incidence rates in Japan in 1996: estimates based on data from 10 population-based cancer registries.

Authors:  W Ajiki; N Kinoshita; H Tsukuma; A Oshima
Journal:  Jpn J Clin Oncol       Date:  2001-08       Impact factor: 3.019

4.  Tumor size is irrelevant in predicting malignant potential of carcinoid tumors of the rectum.

Authors:  S M Heah; K W Eu; B S Ooi; Y H Ho; F Seow-Choen
Journal:  Tech Coloproctol       Date:  2001-08       Impact factor: 3.781

5.  Colorectal cancer statistics in Japan: data from JSCCR registration, 1974-1993.

Authors:  T Muto; K Kotake; Y Koyama
Journal:  Int J Clin Oncol       Date:  2001-08       Impact factor: 3.402

6.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Authors:  Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

7.  Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours.

Authors:  E Bajetta; L Ferrari; G Procopio; L Catena; E Ferrario; A Martinetti; M Di Bartolomeo; R Buzzoni; L Celio; M Vitali; E Beretta; E Seregni; E Bombardieri
Journal:  Ann Oncol       Date:  2002-04       Impact factor: 32.976

8.  Changing site distribution of colorectal cancer in Japan.

Authors:  Hideho Takada; Tsunehide Ohsawa; Shigeyoshi Iwamoto; Ryo Yoshida; Masataka Nakano; Seiki Imada; Kazuhiko Yoshioka; Masashi Okuno; Yoshiro Masuya; Kenji Hasegawa; Naoko Kamano; Koshiro Hioki; Tetsuichiro Muto; Yasuo Koyama
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

9.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

10.  Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97.

Authors:  F Levi; V C Te; L Randimbison; G Rindi; C La Vecchia
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

View more
  92 in total

1.  Ligation-assisted endoscopic submucosal resection with circumferential mucosal incision for duodenal carcinoid tumor.

Authors:  Hideaki Harada; Satoshi Suehiro; Takanori Shimizu; Yasushi Katsuyama; Kenji Hayasaka; Hideto Ito
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

2.  A tailored approach for endoscopic treatment of small rectal neuroendocrine tumor.

Authors:  Jun Heo; Seong Woo Jeon; Min Kyu Jung; Sung Kook Kim; Geun Young Shin; Sang Man Park; Sun Young Ahn; Won Kyung Yoon; Min Kim; Yong Hwan Kwon
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

3.  Goblet cell carcinoid of the rectum with lymph node metastasis: report of a case.

Authors:  Takumi Yamabuki; Makoto Omi; Atsuya Yonemori; Satoshi Hayama; Soichi Murakami; Hitoshi Inomata; Michio Mori; Kazuyoshi Nihei
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.

Authors:  Masau Sekiguchi; Shigeki Sekine; Taku Sakamoto; Yosuke Otake; Takeshi Nakajima; Takahisa Matsuda; Hirokazu Taniguchi; Ryoji Kushima; Yuichiro Ohe; Yutaka Saito
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

5.  PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.

Authors:  Juha Jernman; Pauliina Kallio; Jaana Hagström; Matti J Välimäki; Hannu Haapasalo; Kari Alitalo; Johanna Arola; Caj Haglund
Journal:  Virchows Arch       Date:  2015-06-11       Impact factor: 4.064

Review 6.  Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance.

Authors:  Hans Scherübl; Guillaume Cadiot
Journal:  Visc Med       Date:  2017-10-10

7.  Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.

Authors:  Dong Hyun Kim; Jin Ha Lee; Yoon Jin Cha; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Hoguen Kim; Won Ho Kim; Sung Pil Hong
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

Review 8.  Perspective on the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms.

Authors:  Mitsuhiro Fujishiro
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  Lymph-node metastases in rectal carcinoids.

Authors:  Yoshiya Fujimoto; Masatoshi Oya; Hiroya Kuroyanagi; Masashi Ueno; Takashi Akiyoshi; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  Langenbecks Arch Surg       Date:  2008-12-02       Impact factor: 3.445

10.  Endoscopic mucosal resection for rectal carcinoids under micro-probe ultrasound guidance.

Authors:  Fu-Run Zhou; Liu-Ye Huang; Cheng-Rong Wu
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.